Profiel
Richard K.
Kim worked as the Chief Medical Officer & SVP-Clinical Development at XenoPort, Inc. from 2014 to 2016.
Prior to that, he obtained an undergraduate degree from the University of California, Los Angeles and a doctorate degree from Tulane University (Louisiana).
Eerdere bekende functies van Richard K. Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| XENOPORT, INC. | Chief Tech/Sci/R&D Officer | 01-10-2016 |
Opleiding van Richard K. Kim
| University of California, Los Angeles | Undergraduate Degree |
| Tulane University (Louisiana) | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
